首页> 外文期刊>Journal of Medicinal Chemistry >Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
【24h】

Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents

机译:稳定的秋水仙碱结合位点微管蛋白抑制剂作为潜在抗癌药的设计,合成和生物学评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To block the metabolically labile sites of novel tubulin inhibitors targeting the colchicine binding site based on SMART, ABI, and PAT templates, we have designed, synthesized, and biologically tested three focused sets of new derivatives with modifications at the carbonyl linker, the paraposition in the C ring of SMART template, and modification of A ring of the PAT template. Structure?activity relationships of these compounds led to the identification of new benzimidazole and imidazo[4,5-c]pyridine-fused ring templates, represented by compounds 4 and 7, respectively, which showed enhanced antitumor activity and substantially improved the metabolic stability in liver microsomes compared to SMART. MOM group replaced TMP C ring and generated a potent analogue 15, which showed comparable potency to the parent SMART compound. Further modification of PAT template yielded another potent analogue 33 with 5-indolyl substituent at A ring.
机译:为了基于SMART,ABI和PAT模板阻断靶向秋水仙碱结合位点的新型微管蛋白抑制剂的代谢不稳定位点,我们设计,合成并生物测试了三组新的聚焦衍生物,这些衍生物在羰基接头处进行了修饰, SMART模板的C环和PAT模板的A环的修改。这些化合物的结构活性关系导致鉴定新的苯并咪唑和咪唑并[4,5-c]吡啶稠合的环模板,分别由化合物4和7表示,它们显示出增强的抗肿瘤活性并大大改善了其代谢稳定性。肝微粒体与SMART相比。 MOM组取代了TMP C环并生成了一个强效的类似物15,它的效价与母体SMART化合物相当。 PAT模板的进一步修饰产生在A环具有5-吲哚基取代基的另一个有效的类似物33。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号